<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21217" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Epidermolytic Hyperkeratosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rice</surname>
            <given-names>Ashley S.</given-names>
          </name>
          <aff>CUSOM/Sampson Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Crane</surname>
            <given-names>Jonathan S.</given-names>
          </name>
          <aff>Sampson Regional Med Ctr / Campbell Univ</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ashley Rice declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jonathan Crane declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21217.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Epidermolytic hyperkeratosis (bullous ichthyosiform erythroderma) is a rare autosomal dominant disorder of cornification caused by mutations in keratins 1 and 10. It is characterized by erythroderma and blistering at birth, with subsequent development of hyperkeratosis. This activity reviews the evaluation and management of epidermolytic hyperkeratosis and explains the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of epidermolytic hyperkeratosis (bullous ichthyosiform erythroderma).</p></list-item><list-item><p>Review the history, physical, and evaluation of epidermolytic hyperkeratosis (bullous ichthyosiform erythroderma).</p></list-item><list-item><p>Outline the treatment and management options available for epidermolytic hyperkeratosis (bullous ichthyosiform erythroderma).</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to advance epidermolytic hyperkeratosis (bullous ichthyosiform erythroderma) and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21217&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21217">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21217.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Epidermolytic hyperkeratosis is a rare autosomal dominant pathology of cornification caused by mutations in keratins 1 and 10. It was originally termed bullous congenital ichthyosiform erythroderma owing to the hallmark features of erythroderma, blistering and skin denudation present at birth and subsequent development of marked hyperkeratosis. This presentation occurs with or without palmoplantar keratoderma. Epidermolytic hyperkeratosis is easily distinguishable from other forms of congenital ichthyoses via its highly characteristic histologic findings. In more recent literature, epidermolytic hyperkeratosis has the designation as a pathologic term, and the disease entity has the name of epidermolytic ichthyosis.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r2">[2]</xref><xref ref-type="bibr" rid="article-21217.r3">[3]</xref></p>
      </sec>
      <sec id="article-21217.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Epidermolytic hyperkeratosis is primarily the result of point or missense mutations in the genes encoding keratin 1 (KRT1) and keratin 10 (KRT10).<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r4">[4]</xref><xref ref-type="bibr" rid="article-21217.r2">[2]</xref><xref ref-type="bibr" rid="article-21217.r5">[5]</xref><xref ref-type="bibr" rid="article-21217.r6">[6]</xref> The majority of cases transmit through an autosomal dominant pattern of inheritance.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r2">[2]</xref><xref ref-type="bibr" rid="article-21217.r7">[7]</xref>&#x000a0;A severe form of epidermolytic hyperkeratosis exists in three consanguineous pedigrees due to autosomal recessive loss-of-function mutations in keratin 10.<xref ref-type="bibr" rid="article-21217.r2">[2]</xref><xref ref-type="bibr" rid="article-21217.r8">[8]</xref><xref ref-type="bibr" rid="article-21217.r9">[9]</xref>&#x000a0;Sporadic mutations occur in up to 50% of cases.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r2">[2]</xref><xref ref-type="bibr" rid="article-21217.r7">[7]</xref>&#x000a0;Mutations in keratin 1 have been associated with epidermolytic hyperkeratosis with severe palmoplantar keratoderma, while mutations in keratin 10 cause a phenotype lacking palmoplantar keratoderma.<xref ref-type="bibr" rid="article-21217.r7">[7]</xref><xref ref-type="bibr" rid="article-21217.r10">[10]</xref></p>
        <p>The offspring of parents with epidermal nevi may have generalized epidermolytic hyperkeratosis due to genetic mosaicism. The mosaic form of epidermolytic hyperkeratosis, variably labeled ichthyosis hystrix or linear epidermolytic hyperkeratosis, is caused by postzygotic mutations in keratin 1 and keratin 10 during embryogenesis. If these mutations involve gonadal cells, they can be transmitted to offspring and cause phenotypical epidermolytic hyperkeratosis.<xref ref-type="bibr" rid="article-21217.r7">[7]</xref><xref ref-type="bibr" rid="article-21217.r11">[11]</xref>&#x000a0;Currently, epidermolytic hyperkeratosis is the only known human keratin disease to exhibit genetic mosaicism.<xref ref-type="bibr" rid="article-21217.r7">[7]</xref></p>
      </sec>
      <sec id="article-21217.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Epidermolytic hyperkeratosis has been reported to affect 1 in 200000 to 300000 infants.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r12">[12]</xref> The disorder is predominantly autosomal dominant, and therefore, there is no gender predilection.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref></p>
      </sec>
      <sec id="article-21217.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Epidermolytic hyperkeratosis is caused by mutations that disrupt the keratin network of the epidermis. Keratin proteins are the most important proteins necessary for the structural development of the epidermis.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r13">[13]</xref>&#x000a0;The epidermis protects the skin from environmental conditions by forming a massive cytoskeletal structure of keratin filaments. Genes encoding keratin 5 and keratin 14 get expressed in the basal layer of the epidermis. As the epidermal cells continue to terminally differentiate, the suprabasal cells are made up of keratin 1 and keratin 10 filaments, which are thicker than the tonofilament bundles of basal cells. Thicker tonofilament bundles&#x000a0;allow for enhanced survival of keratins.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r14">[14]</xref><xref ref-type="bibr" rid="article-21217.r15">[15]</xref></p>
        <p>Mutations in epidermolytic hyperkeratosis occur in the highly conserved a-helical rod domains of keratin 1 and keratin 10. Mutations in helix boundary sequence motifs affect helix initiation and termination motifs and lead to significantly disrupted filament assembly, tonofilament aggregation and generally, more severe phenotypes. The compromised epidermis is in turn prone to cytolysis and blistering, leading to disruption in the skin barrier function, causing increased transepidermal water loss and bacterial colonization.<xref ref-type="bibr" rid="article-21217.r7">[7]</xref>&#x000a0;Hyperkeratosis results from hyperproliferation in the basal cells and decreased desquamation.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref></p>
        <p>Chipev et al. discovered via electron microscopy a leucine to a proline point mutation in the H1 sub-domain of the intermediate keratin 1 filament that significantly disrupted the structure and organization of keratin filaments.<xref ref-type="bibr" rid="article-21217.r4">[4]</xref>.&#x000a0;Snyder et al. identified an arginine to histidine mutation in the amino end of the a-helical rod domain of KRT10 and tyrosine to cysteine mutation in the carboxy-domain of KRT1.<xref ref-type="bibr" rid="article-21217.r16">[16]</xref>&#x000a0;Severe forms of epidermolytic hyperkeratosis have associations with deletion of exon 6 of KRT1<xref ref-type="bibr" rid="article-21217.r6">[6]</xref>&#x000a0;and missense mutations (c.475T&#x0003e;C;p.Ser159Pro and c.562A&#x0003e;C;p.N188H) in KRT10 and KRT1, respectively.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r17">[17]</xref></p>
      </sec>
      <sec id="article-21217.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Characteristic histopathologic findings distinguish epidermolytic hyperkeratosis from other congenital ichthyoses. Prominent features on histology include dense orthohyperkeratosis, hypergranulosis, coarse keratohyaline granules and cytolysis of the suprabasal and granular layers. Keratinocytes demonstrate marked intracellular vacuolar degeneration and dense clumps of keratin intermediate filaments. Varying degrees of dyskeratosis and a mild perivascular lymphohistiocytic infiltrate also occur. Electron microscopy shows clumped keratin intermediate filaments at the suprabasal layer, and immunohistochemistry shows defects in keratins 1 or 10.<xref ref-type="bibr" rid="article-21217.r12">[12]</xref>&#x000a0;Patients with the mosaic form of epidermolytic hyperkeratosis exhibit focal areas of involvement with skip areas of normal epidermis.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r2">[2]</xref></p>
      </sec>
      <sec id="article-21217.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Epidermolytic hyperkeratosis appears at birth with generalized erythroderma. Skin fragility causes blisters, peeling/exfoliation, erosions, and widespread areas of denuded skin, even with minor trauma. After several months, the erythema and blistering decrease and marked hyperkeratosis develop. Occasionally, skin fragility persists, and patients periodically shed large plates of the superficial epidermis. Hyperkeratosis characteristically&#x000a0;resembles &#x0201c;corrugated cardboard&#x0201d; when overlying flexural areas or "cobblestoning" when overlying the extensor surfaces of joints. Occasionally, severe scalp and neck involvement occur, leading to encasement of hair shafts and alopecia. Bacterial colonization of the macerated scales causes a distinctive foul odor resembling rotten eggs. Commonly associated symptoms include xerosis, pruritus, painful fissuring, anhidrosis, and decreased range of motion of joints.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r12">[12]</xref></p>
        <p>Researchers have identified several different phenotypes of epidermolytic hyperkeratosis. In 1994, DiGiovanna and Bale described two main clinical categories: with palmoplantar keratoderma and without palmoplantar keratoderma.<xref ref-type="bibr" rid="article-21217.r18">[18]</xref> Each clinical category has three subtypes with varying degrees of erythroderma, blistering, scaling (non-palmoplantar type), and truncal involvement (palmoplantar type).<xref ref-type="bibr" rid="article-21217.r12">[12]</xref>&#x000a0;Digital contractures from palmoplantar involvement can lead to functional impairment. The mosaic form of epidermolytic hyperkeratosis features unilateral or bilateral streaks of hyperkeratosis in a Blaschkoid distribution.<xref ref-type="bibr" rid="article-21217.r7">[7]</xref><xref ref-type="bibr" rid="article-21217.r11">[11]</xref>&#x000a0;Those with more extensive involvement and lesions with protruding, porcupine-like spines have been termed &#x0201c;ichthyosis hystrix.&#x0201d;<xref ref-type="bibr" rid="article-21217.r7">[7]</xref></p>
      </sec>
      <sec id="article-21217.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnostic basis is on clinical, histopathologic, and laboratory findings. Genetic mutation analysis for keratin defects with multigene-panel screening is the current gold standard and is usable for prenatal screening.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r12">[12]</xref>&#x000a0;Prenatal diagnosis is obtainable via chorionic villus sampling, amniocentesis, and fetoscopy with a fetal skin biopsy.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r12">[12]</xref>&#x000a0;However, these studies have limitations of low sensitivity or genetic heterogeneity. Optical and spectroscopic techniques such as the Raman spectroscopy and optical coherence tomography have been used in in-vivo identification of nonmelanoma skin cancers and may be a potential diagnostic technique for epidermolytic hyperkeratosis.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref></p>
      </sec>
      <sec id="article-21217.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment is predominantly symptomatic and depends on the patient&#x02019;s age and presentation. Infants should be monitored in the intensive care setting to manage dehydration, electrolyte imbalance, and cutaneous superinfection. Sepsis treatment should be with broad-spectrum intravenous antibiotics. Topical emollients and protective padding should be used for skin protection and to heal denuded areas.<xref ref-type="bibr" rid="article-21217.r12">[12]</xref></p>
        <p>The goal of therapy in children and adults is a reduction in hyperkeratosis. Topical emollients and keratolytic agents containing glycerin, lactic acid, urea, and a-hydroxy acids have demonstrated improvement in hyperkeratosis but are often not well tolerated due to burning and stinging. Clinicians should avoid widespread use of higher concentration salicylic acid topical preparations because of the risk of systemic salicylism.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r12">[12]</xref>&#x000a0;Topical retinoids, N-acetylcysteine, liarozole, and calcipotriol have been shown to affect corneocyte function and decrease epidermal hyperproliferation. However, these agents may also cause skin irritation.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref>&#x000a0;In severe cases of epidermolytic hyperkeratosis, oral retinoids may&#x000a0;dramatically improve hyperkeratosis and frequency of superinfection but can paradoxically increase skin fragility and exacerbate blistering. Thus, it is recommended to use low initial doses and then gradually increase with careful monitoring.<xref ref-type="bibr" rid="article-21217.r19">[19]</xref>&#x000a0;Of note, patients with keratin 10 mutations respond better to topical or systemic retinoids compared to patients with keratin 1 mutations.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r12">[12]</xref>&#x000a0;Antibacterial soaps, chlorhexidine, and dilute sodium hypochlorite baths can decrease bacterial colonization. Topical or systemic antibiotics are needed when bacterial skin infection occurs.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r12">[12]</xref></p>
      </sec>
      <sec id="article-21217.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of epidermolytic hyperkeratosis includes other causes of erythroderma, bullae/blisters, or exfoliation in childhood.</p>
        <p>Other congenital ichthyoses:</p>
        <list list-type="bullet">
          <list-item>
            <p>Superficial epidermolytic ichthyosis</p>
          </list-item>
          <list-item>
            <p>Lamellar ichthyosis</p>
          </list-item>
          <list-item>
            <p>Congenital ichthyosiform erythroderma</p>
          </list-item>
        </list>
        <p>Vesiculobullous and erosive disorders in childhood:</p>
        <list list-type="bullet">
          <list-item>
            <p>Epidermolysis bullosa</p>
          </list-item>
          <list-item>
            <p>Staphylococcal scalded skin syndrome</p>
          </list-item>
          <list-item>
            <p>Bullous impetigo</p>
          </list-item>
          <list-item>
            <p>Herpes simplex</p>
          </list-item>
          <list-item>
            <p>Congenital erosive and vesicular dermatosis</p>
          </list-item>
          <list-item>
            <p>Autoimmune blistering diseases</p>
          </list-item>
        </list>
        <p>Genodermatoses:</p>
        <list list-type="bullet">
          <list-item>
            <p>Sjogren-Larsson syndrome</p>
          </list-item>
          <list-item>
            <p>Neutral lipid storage disease</p>
          </list-item>
          <list-item>
            <p>Trichothiodystrophy</p>
          </list-item>
          <list-item>
            <p>Netherton syndrome</p>
          </list-item>
          <list-item>
            <p>Steroid sulfatase deficiency</p>
          </list-item>
          <list-item>
            <p>Peeling skin syndromes</p>
          </list-item>
          <list-item>
            <p>Conradi-Hunermann-Happle syndrome</p>
          </list-item>
          <list-item>
            <p>CHILD syndrome</p>
          </list-item>
          <list-item>
            <p>KID syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21217.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The severity of epidermolytic hyperkeratosis is variable.&#x000a0;Neonates with this disorder are at increased risk of sepsis, dehydration and ultimately, death. Due to the rarity of this disorder, statistics on mortality rate are lacking.&#x000a0;For those that survive the neonatal period, episodes of blistering and skin infections occur intermittently throughout life. As a result, patients often have significant disfigurement and pungent body odors, causing severe&#x000a0;psychological and social distress.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref><xref ref-type="bibr" rid="article-21217.r12">[12]</xref></p>
      </sec>
      <sec id="article-21217.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Neonates born with epidermolytic hyperkeratosis are at higher risk of dehydration, electrolyte imbalances, and sepsis due to increased transepidermal water loss and ineffective skin barrier function. Without proper treatment, these complications are fatal. Also, severe palmoplantar involvement can lead to digital contractures, which can negatively affect joint mobility, gait, and posture.<xref ref-type="bibr" rid="article-21217.r12">[12]</xref></p>
      </sec>
      <sec id="article-21217.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with epidermolytic hyperkeratosis have increased skin fragility throughout their life, and therefore, it is essential to educate patients on ways to minimize mechanical trauma. This is possible by wearing loose-fitting, comfortable clothes, and well-fitting shoes.</p>
      </sec>
      <sec id="article-21217.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Epidermolytic hyperkeratosis usually presents soon after birth. It has no cure, and the disorder is progressive. Treatment is primarily symptomatic and depends on the patient&#x02019;s age and presentation. Physician management involves the family doctor, pediatrician, and dermatologist, as well as the NP and PA. Infants should be monitored in the intensive care setting to manage dehydration, electrolyte imbalance, and cutaneous superinfection. Sepsis should receive treatment with broad-spectrum intravenous antibiotics, which should have input from the pharmacist for coverage, dosing, and monitoring for drug interactions. The nurse should educate the caregiver or parent on the use of topical emollients and protective padding for skin protection and heal denuded areas, which can also have pharmacy input. Because the skin is fragile, the nurse practitioner should also educate patients on ways to minimize mechanical trauma, which is achievable by wearing loose-fitting, comfortable clothes, and well-fitting shoes.</p>
        <p>Because of the considerable psychosocial morbidity caused by long-term sequelae of epidermolytic hyperkeratosis, it is necessary to coordinate care with an interprofessional team including intensivists, infectious disease specialists, mental health nurse, and psychiatrists. Delays in diagnosis and management can produce negative outcomes and possible death. All these members of the interprofessional healthcare team need to collaborate and communicate to bring about positive patient outcomes.<xref ref-type="bibr" rid="article-21217.r1">[1]</xref> [Level 5]</p>
      </sec>
      <sec id="article-21217.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21217&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21217">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/epidermolytic-hyperkeratosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21217">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21217/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21217">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-21217.s16">
        <fig id="article-21217.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Skin Fragility&#x000a0;in Epidermolytic Hyperkeratosis. This image shows marked exfoliation in a patient with&#x000a0;epidermolytic hyperkeratosis. Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="epidermolytic__hyperkeratosis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21217.s17">
        <fig id="article-21217.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Hyperkeratosis in Epidermolytic Hyperkeratosis. Severe hyperkeratosis in a young patient with&#x000a0;epidermolytic hyperkeratosis. Contributed by Dr. Shyam Verma, MBBS, DVD, FRCP, FAAD, Vadodara, India</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="epidermolytic__hyperkeratosisSV" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-21217.s18">
        <title>References</title>
        <ref id="article-21217.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peter Rout</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Epidermolytic hyperkeratosis: clinical update.</article-title>
            <source>Clin Cosmet Investig Dermatol</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>333</fpage>
            <page-range>333-344</page-range>
            <pub-id pub-id-type="pmid">31190940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Covaciu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Castori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Luca</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ghirri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nannipieri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ragone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zambruno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Castiglia</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Lethal autosomal recessive epidermolytic ichthyosis due to a novel donor splice-site mutation in KRT10.</article-title>
            <source>Br J Dermatol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>162</volume>
            <issue>6</issue>
            <fpage>1384</fpage>
            <page-range>1384-7</page-range>
            <pub-id pub-id-type="pmid">20302579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oji</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tadini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Akiyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blanchet Bardon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bodemer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bourrat</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Coudiere</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>DiGiovanna</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Elias</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fleckman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hausser</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hennies</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Hohl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hovnanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ishida-Yamamoto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jacyk</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Leachman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leigh</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mazereeuw-Hautier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Milstone</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Morice-Picard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Paller</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schmuth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sprecher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Van Steensel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ta&#x000ef;eb</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Toro</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Vabres</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vahlquist</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Traupe</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sor&#x000e8;ze 2009.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>63</volume>
            <issue>4</issue>
            <fpage>607</fpage>
            <page-range>607-41</page-range>
            <pub-id pub-id-type="pmid">20643494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chipev</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Korge</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Markova</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bale</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>DiGiovanna</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Compton</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Steinert</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>A leucine----proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis.</article-title>
            <source>Cell</source>
            <year>1992</year>
            <month>Sep</month>
            <day>04</day>
            <volume>70</volume>
            <issue>5</issue>
            <fpage>821</fpage>
            <page-range>821-8</page-range>
            <pub-id pub-id-type="pmid">1381288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishida-Yamamoto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McGrath</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Judge</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Leigh</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Eady</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma).</article-title>
            <source>J Invest Dermatol</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>99</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-26</page-range>
            <pub-id pub-id-type="pmid">1376754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Virtanen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Gedde-Dahl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vahlquist</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bowden</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Splice site and deletion mutations in keratin (KRT1 and KRT10) genes: unusual phenotypic alterations in Scandinavian patients with epidermolytic hyperkeratosis.</article-title>
            <source>J Invest Dermatol</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>121</volume>
            <issue>5</issue>
            <fpage>1013</fpage>
            <page-range>1013-20</page-range>
            <pub-id pub-id-type="pmid">14708600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Irvine</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation.</article-title>
            <source>Br J Dermatol</source>
            <year>1999</year>
            <month>May</month>
            <volume>140</volume>
            <issue>5</issue>
            <fpage>815</fpage>
            <page-range>815-28</page-range>
            <pub-id pub-id-type="pmid">10354017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kinaciyan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hausser</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Schaffrath</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Krieg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hohl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Korge</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Arin</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis.</article-title>
            <source>Hum Mol Genet</source>
            <year>2006</year>
            <month>Apr</month>
            <day>01</day>
            <volume>15</volume>
            <issue>7</issue>
            <fpage>1133</fpage>
            <page-range>1133-41</page-range>
            <pub-id pub-id-type="pmid">16505000</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsubota</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Akiyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kanitakis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nomura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Claudy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Mild recessive bullous congenital ichthyosiform erythroderma due to a previously unidentified homozygous keratin 10 nonsense mutation.</article-title>
            <source>J Invest Dermatol</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>128</volume>
            <issue>7</issue>
            <fpage>1648</fpage>
            <page-range>1648-52</page-range>
            <pub-id pub-id-type="pmid">18219278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DiGiovanna</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Bale</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical heterogeneity in epidermolytic hyperkeratosis.</article-title>
            <source>Arch Dermatol</source>
            <year>1994</year>
            <month>Aug</month>
            <volume>130</volume>
            <issue>8</issue>
            <fpage>1026</fpage>
            <page-range>1026-35</page-range>
            <pub-id pub-id-type="pmid">8053700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paller</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Syder</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>QC</given-names>
              </name>
              <name>
                <surname>Hutton</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tadini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fuchs</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Genetic and clinical mosaicism in a type of epidermal nevus.</article-title>
            <source>N Engl J Med</source>
            <year>1994</year>
            <month>Nov</month>
            <day>24</day>
            <volume>331</volume>
            <issue>21</issue>
            <fpage>1408</fpage>
            <page-range>1408-15</page-range>
            <pub-id pub-id-type="pmid">7526210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Maverakis</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Epidermolytic hyperkeratosis.</article-title>
            <source>Dermatol Online J</source>
            <year>2006</year>
            <month>Sep</month>
            <day>08</day>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">16962021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fuchs</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Coulombe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Hutton</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Syder</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Degenstein</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>QC</given-names>
              </name>
              <name>
                <surname>Letai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vassar</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Genetic bases of epidermolysis bullosa simplex and epidermolytic hyperkeratosis.</article-title>
            <source>J Invest Dermatol</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>103</volume>
            <issue>5 Suppl</issue>
            <fpage>25S</fpage>
            <page-range>25S-30S</page-range>
            <pub-id pub-id-type="pmid">7525738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nelson</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>TT</given-names>
              </name>
            </person-group>
            <article-title>The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies.</article-title>
            <source>J Cell Biol</source>
            <year>1983</year>
            <month>Jul</month>
            <volume>97</volume>
            <issue>1</issue>
            <fpage>244</fpage>
            <page-range>244-51</page-range>
            <pub-id pub-id-type="pmid">6190820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roop</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Huitfeldt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kilkenny</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yuspa</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Regulated expression of differentiation-associated keratins in cultured epidermal cells detected by monospecific antibodies to unique peptides of mouse epidermal keratins.</article-title>
            <source>Differentiation</source>
            <year>1987</year>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-50</page-range>
            <pub-id pub-id-type="pmid">2450799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Syder</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>QC</given-names>
              </name>
              <name>
                <surname>Paller</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Giudice</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fuchs</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity.</article-title>
            <source>J Clin Invest</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>93</volume>
            <issue>4</issue>
            <fpage>1533</fpage>
            <page-range>1533-42</page-range>
            <pub-id pub-id-type="pmid">7512983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>CX</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>SQ</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>XB</given-names>
              </name>
            </person-group>
            <article-title>S159P mutation of keratin 10 gene causes severe form of epidermolytic hyperkeratosis.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>10</issue>
            <fpage>e102</fpage>
            <page-range>e102-e104</page-range>
            <pub-id pub-id-type="pmid">26373619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DiGiovanna</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Bale</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Epidermolytic hyperkeratosis: applied molecular genetics.</article-title>
            <source>J Invest Dermatol</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>102</volume>
            <issue>3</issue>
            <fpage>390</fpage>
            <page-range>390-4</page-range>
            <pub-id pub-id-type="pmid">7509838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21217.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lacour</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mehta-Nikhar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Atherton</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>An appraisal of acitretin therapy in children with inherited disorders of keratinization.</article-title>
            <source>Br J Dermatol</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>134</volume>
            <issue>6</issue>
            <fpage>1023</fpage>
            <page-range>1023-9</page-range>
            <pub-id pub-id-type="pmid">8763418</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
